Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
AFJK
STRONG SELLREMOVEAimei Health Technology Co., Ltd · Financial Services · United States · $131M · Avg Vol: $94K/d
Aimei Health Technology is a blank-check company. It has no operational history, no products, and no cash flow, making it a speculative vehicle that does not meet any of our fundamental investment criteria.
COMPANY DESCRIPTION
Aimei Health Technology Co., Ltd is a Chinese aesthetic medical services provider, offering a range of non-surgical and surgical beauty treatments through its clinic network. The company focuses on the burgeoning high-end medical aesthetic market, emphasizing advanced technologies and personalized client experiences. Aimei Health Technology aims to expand its market share by catering to increasing demand for beauty and wellness services in China.
FINANCIAL SUMMARY (USD)
| Year | 2024 |
|---|---|
| Revenue | 0 |
| EPS | 0.28 |
| Shares | 9M |
| Debt | 227,700 |
| Equity | 72M |
| Op CF | -672,289 |
| Inv CF | -277,700 |
| Fin CF | 397,480 |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Financial Services, ranked by industry match, size, and score similarity. Cross-listings of AFJK are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| AFJK | Aimei Health Technology Co., Ltd(you) | $131M | 8 | STRONG SELL |
| QUMS | Quantumsphere Acquisition Corporation | $116M | 10 | STRONG SELL |
| FGMC | FG Merger II Corp. | $106M | 8 | STRONG SELL |
| FMAC | Future Money Acquisition Corporation | $158M | 9 | STRONG SELL |
| IPEX | Inflection Point Acquisition Corp. V | $125M | 11 | STRONG SELL |
| SPEG | Silver Pegasus Acquisition Corp. | $157M | 7 | STRONG SELL |
| LKSP | Lake Superior Acquisition Corp. | $159M | 6 | STRONG SELL |
| BHAV | BHAV Acquisition Corp | $144M | 4 | STRONG SELL |
| TAVI | Tavia Acquisition Corp. | $169M | 9 | STRONG SELL |
| PCSC | Perceptive Capital Solutions Corp | $124M | 2 | STRONG SELL |
Peer medians: ROE 10.8% · P/E 13.6x · Gross margin 0.0%